dazzle ai | $8,000,000 | (Jan 7, 2026)
Tesoro XP, Inc. | $5,400,000 | (Jan 7, 2026)
Lemon Slice | $10,500,000 | (Jan 7, 2026)
Elligo Health Research
United States
- Austin, Texas
- 03/10/2023
- Unknown
- $40,000,000
Elligo Health Research accelerates clinical trials through EHR data, our proprietary IntElligo® technology, and direct access to known, diverse patients from more than 115 hospitals and major health systems, 200 healthcare-based sites, and 100 research-based sites. Our PatientSelect® model engages our network of networks to optimize the intersection of healthcare and research and bring more patients clinical research as a care option. Our SiteSelect model and Research Partner Services enable sites to seamlessly participate in trials, further advancing the development of new pharmaceutical, biotechnology, and medical device and diagnostic products.
- Industry Pharmaceutical Manufacturing
- Website https://www.elligohealthresearch.com/
- LinkedIn https://www.linkedin.com/company/elligo-health-research/about/
Related People
John PotthoffFounder
United States -
Austin, Texas Metropolitan Area
For more than 30 years, I’ve focused on helping development service companies excel in the drug/device development industry.
In March 2016, I co-founded and serve as CEO of Elligo Health Research, a company focused on enabling patients and clinicians to participate in clinical trials by providing the needed infrastructure not found at all clinical settings.
From 2011 to 2015, I led Theorem Clinical Research as president and CEO, overseeing the company’s strategy, operational execution and customer experience. In September 2015, after record growth, I led the successful sale of Theorem to Chiltern yielding a record ROI for investors.
Prior to joining Theorem, I served as COO at INC Research. While at INC Research, I helped the company achieve record year-over-year profit by upholding a 40 percent CAGR in sales and revenue for several years. Throughout my career, I oversaw multiple acquisitions, providing the operational guidance for the integration of seven major acquisitions in six years. I played a key role in negotiating the successful sale of INC Research in 2010.
Array Labs | $20,000,000 | (Jan 7, 2026)
Lyte | $107,000,000 | (Jan 7, 2026)
Lucidean | $18,000,000 | (Jan 7, 2026)
CHAMP | $55,000,000 | (Jan 7, 2026)
Truemed | $34,000,000 | (Jan 7, 2026)
Coinbax | $4,200,000 | (Jan 7, 2026)
Peripheral Labs | $3,600,000 | (Dec 23, 2025)
Ciphero | $2,500,000 | (Dec 23, 2025)
Givefront | $2,000,000 | (Dec 23, 2025)